CSO, Anne Phelan talks to Emerj about the challenges of drug discovery and how AI can be used to tackle this

---

CSO, Anne Phelan talks to Emerj about the challenges of drug discovery and how AI can be used to tackle this.

Our Chief Scientific Officer, Anne Phelan, recently joined Emerj to discuss how AI is transforming drug discovery efficiencies.

Anne shares insights into our team's process for developing cutting-edge AI models that predict drug properties, stability, and pharmacological characteristics.

Listen to the full AI in Healthcare & Life Sciences podcast here.

 

 

---

Back to blog post and videos